Odyssey Health, Inc. (ODYY)
OTCMKTS
· Delayed Price · Currency is USD
0.0110
+0.0019 (20.88%)
Mar 12, 2025, 4:00 PM EST
Odyssey Health Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
1.03M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo Inc. | 1.18B |
SS Innovations International | 16.04M |
Veradigm | 1.53B |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 188.29M |
Northwest Biotherapeutics | 1.60M |
Silence Therapeutics | 43.26M |
BioStem Technologies | 210.49M |
Odyssey Health News
- 1 year ago - Odyssey Health, Inc. Strengthens Balance Sheet with $8.7 Million in Net Equity - Accesswire
- 1 year ago - Odyssey Health Closes Asset Sale of its Neurological Drug Technology Pipeline Including Concussion Drug Candidate with Oragenics, Inc. - Accesswire
- 1 year ago - Odyssey Health, Inc. Gains Shareholder Approval for Asset Sale with Oragenics, Inc. - Accesswire
- 1 year ago - Odyssey Health, Inc, Selects Syneos Health to Support Investigational New Drug Application for Treatment of Concussion - Accesswire
- 1 year ago - Odyssey Health, Inc. to Provide Company Update and Webcast for Shareholders - Accesswire
- 1 year ago - Odyssey Health, Inc. Provides Update on Asset Purchase Agreement with Oragenics, Inc. - Accesswire
- 1 year ago - Odyssey Health Inc. Begins Trading on the OTCQB - Accesswire
- 1 year ago - Odyssey Health, Inc. Presents Concussion Treatment Data at the Military Health System Research Symposium - MHSRS - Accesswire